Stock Research for ANIP

ANIP

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ANIP Stock Chart & Research Data

The ANIP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ANIP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ANIP Due diligence Resources & Stock Charts

The ANIP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ANIP Detailed Price Forecast - CNN Money CNN View ANIP Detailed Summary - Google Finance
Yahoo View ANIP Detailed Summary - Yahoo! Finance Zacks View ANIP Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ANIP Trends & Analysis - Trade-Ideas Barrons View ANIP Major Holders - Barrons
NASDAQ View ANIP Call Transcripts - NASDAQ Seeking View ANIP Breaking News & Analysis - Seeking Alpha
Spotlight View ANIP Annual Report - CompanySpotlight.com OTC Report View ANIP OTC Short Report - OTCShortReport.com
TradeKing View ANIP Fundamentals - TradeKing Charts View ANIP SEC Filings - Bar Chart
WSJ View Historical Prices for ANIP - The WSJ Morningstar View Performance/Total Return for ANIP - Morningstar
MarketWatch View the Analyst Estimates for ANIP - MarketWatch CNBC View the Earnings History for ANIP - CNBC
StockMarketWatch View the ANIP Earnings - StockMarketWatch MacroAxis View ANIP Buy or Sell Recommendations - MacroAxis
Bullish View the ANIP Bullish Patterns - American Bulls Short Pains View ANIP Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ANIP Stock Mentions - StockTwits PennyStocks View ANIP Stock Mentions - PennyStockTweets
Twitter View ANIP Stock Mentions - Twitter Invest Hub View ANIP Investment Forum News - Investor Hub
Yahoo View ANIP Stock Mentions - Yahoo! Message Board Seeking Alpha View ANIP Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ANIP - SECform4.com Insider Cow View Insider Transactions for ANIP - Insider Cow
CNBC View ANIP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ANIP - OTC Markets
Yahoo View Insider Transactions for ANIP - Yahoo! Finance NASDAQ View Institutional Holdings for ANIP - NASDAQ


Stock Charts

FinViz View ANIP Stock Insight & Charts - FinViz.com StockCharts View ANIP Investment Charts - StockCharts.com
BarChart View ANIP Stock Overview & Charts - BarChart Trading View View ANIP User Generated Charts - Trading View




Latest Financial News for ANIP


ANI Pharmaceuticals to Present at New Time at the Canaccord Genuity 38th Annual Growth Conference
Posted on Wednesday August 08, 2018

Arthur S. Przybyl, President and CEO and Stephen P. Carey, Vice President, Finance and CFO, will present on behalf of ANI Pharmaceuticals, Inc. The presentation will be webcast live at http://wsw.com/webcast/canaccord30/anip/ and will be archived and available through the link through November 7, 2018. ANI Pharmaceuticals, Inc. (the "Company" or "ANI") is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals.


ANI Pharmaceuticals (ANIP) Lags Q2 Earnings and Revenue Estimates
Posted on Tuesday August 07, 2018

ANI (ANIP) delivered earnings and revenue surprises of -13.08% and -6.77%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?


ANI: 2Q Earnings Snapshot
Posted on Tuesday August 07, 2018

On a per-share basis, the Baudette, Minnesota-based company said it had profit of 23 cents. Earnings, adjusted for one-time gains and costs, were $1.13 per share. The drugmaker posted revenue of $47.3 ...


ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance
Posted on Tuesday August 07, 2018

Acquires WellSpring Pharma Services for $18 Million in Cash to Expand Contract Manufacturing Business and Accelerate ANDA Pipeline Re-commercialization Efforts Targets sNDA Filing for Cortrophin Gel by ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.